Consensus Option Care Health, Inc.

Equities

OPCH

US68404L2016

Market Closed - Nasdaq 04:00:00 2024-07-02 pm EDT 5-day change 1st Jan Change
27.54 USD +0.73% Intraday chart for Option Care Health, Inc. -2.20% -18.25%

Evolution of the average Target Price on Option Care Health, Inc.

Price target over the last 5 years

History of analyst recommendation changes

bd2b136e040e95239bccbbc2fcc7b.PEDwHEo_vfns-qa10hxGJ8yIzyI4Fv6POz3XQt06qH0.VhSYUHgO64iiqtXcmCgvTbT4nlJ8YI7-S2zmBZxu8BZJBMFrDlmOlquX4w~8f719afb6b26df95eaa7c5ba5c0b5cc7
Jefferies Adjusts Price Target on Option Care Health to $38 From $36, Maintains Buy Rating MT
Deutsche Bank Adjusts Option Care Health Price Target to $36 From $35, Maintains Buy Rating MT
Barrington Boosts Price Target on Option Care Health to $38 From $35, Maintains Outperform Rating MT
Deutsche Bank Cuts Option Care Health Price Target to $35 From $39, Maintains Buy Rating MT
Barrington Cuts Price Target on Option Care Health to $35 From $41 After Solid Q3 Earnings, Keeps Outperform Rating MT
JPMorgan Cuts Price Target on Option Care Health to $44 From $46, Maintains Overweight Rating MT
Deutsche Bank Adjusts Option Care Health Price Target to $39 From $32.50, Maintains Buy Rating MT
Barrington Ups Price Target on Option Care Health to $41 From $34, Maintains Outperform Rating MT
Deutsche Bank Adjusts Option Care Health Price Target to $32.50 From $39, Maintains Buy Rating MT
Jefferies Reinstates Option Care Health at Buy With $38 Price Target MT
Barrington Research Adjusts Option Care Health's Price Target to $38 From $37, Keeps Outperform Rating MT
Goldman Sachs Adjusts Option Care Health's Price Target to $40 From $31, Maintains Buy Rating MT
Barrington Research Raises Option Care Health's Price Target to $37 From $33, Maintains Outperform Rating MT
Deutsche Bank Adjusts Option Care Health Price Target to $39 From $32, Maintains Buy Rating MT
Barrington Raises Option Care Health's Price Target to $33 From $31, Maintains Outperform Rating MT
Barrington Adjusts Price Target on Option Care Health to $31 From $28 After Q3 Earnings Beat, Maintains Outperform Rating MT
Deutsche Bank Adjusts Option Care Health PT to $32 From $23.50, Maintains Buy Rating MT
OPTION CARE HEALTH : Goldman Sachs Adjusts Option Care Health PT to $30 From $26, Maintains Buy Rating MT
OPTION CARE HEALTH : Lake Street Adjusts Price Target on Option Care Health to $35 From $27, Maintains Buy Rating MT
OPTION CARE HEALTH : Canaccord Genuity Adjusts Price Target on Option Care Health to $24 From $22, Reiterates Buy Rating MT
OPTION CARE HEALTH : Barrington Adjusts Price Target on Option Care Health to $28 From $24 After Q2 Earnings Beat, Maintains Outperform Rating MT
OPTION CARE HEALTH : Lake Street Adjusts Option Care Health PT to $27 From $25, Maintains Buy Rating MT
OPTION CARE HEALTH : Goldman Sachs Lifts Option Care Health to Buy From Neutral, Price Target to $25 From $20 MT
OPTION CARE HEALTH : Canaccord Adjusts Option Care Health's Price Target to $24 from $20, Keeps Buy MT
OPTION CARE HEALTH : Barrington Adjusts Price Target on Option Care Health to $24 From $19, Maintains Outperform Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
27.54 USD
Average target price
39.43 USD
Spread / Average Target
+43.17%
High Price Target
43 USD
Spread / Highest target
+56.14%
Low Price Target
36 USD
Spread / Lowest Target
+30.72%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Option Care Health, Inc.

Jefferies & Co.
Deutsche Bank Securities
Barrington Research
JPMorgan Chase
Goldman Sachs
Lake Street
Canaccord Genuity
  1. Stock Market
  2. Equities
  3. OPCH Stock
  4. Consensus Option Care Health, Inc.